Rebalancing Blood Clotting and Revealing Fossil Forgery

The chapter delves into a new approach for managing blood clot formation in bleeding disorders by targeting the enzyme plasmin, ensuring stable clotting. It discusses a breakthrough therapy successfully reducing bleeding problems in animal models without increased thrombosis risk. Additionally, the revelation of a 300-million-year-old reptile fossil being identified as a forgery raises concerns about the authenticity of fossils and the need for their protection.